Restificar, Pascuala A.
HRN: 22-47-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/11/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/11/2023
01/17/2023
IV
1.5g
Q6h
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes